LiverScan aims to identify individuals with potential liver disease and fatty livers using the gold standard examination with a FibroScan device. Every day in the UK, more than 40 people die from liver disease and 25% of the adult population are currently estimated to have non-alcoholic fatty liver disease (NAFLD). Our aim is to be one step ahead and encourage people to take control of their liver health.
The company was formed by a group of friends with medical, health and business angel backgrounds. One of the group came across the FibroScan device following his own MRI examination which was not targeting the liver, but which indicated a potential fatty liver. That diagnosis lead to an examination using the FibroScan device, carried out by a hepatologist. Without that MRI scan identifying an issue, and because most liver disease is asymptomatic, the fatty liver issue would not have been identified, addressed or resolved.
The examination using the FibroScan device, a non-invasive ultrasound procedure, produces 2 results: liver fat (CAP) and liver stiffness (LSM) scores. Fatty liver disease can lead to liver inflammation, scarring and eventually liver cirrhosis or liver cancer. Whilst alcohol can be the cause, in the UK, roughly half of liver disease is classified as NAFLD. It is hugely important that liver disease is caught early, and with simple changes in lifestyle, the damage can often be reversed, partly because of the regenerative nature of the organ itself.
Our group of shareholders all quickly bought into the importance of liver health and the benefits that could result from introducing examinations using the FibroScan device within Scotland on a self-referral basis.
We have also established an advisory board to review our clinical operations, who provide valuable expertise and guidance to optimise our service and ensure patient-centric excellence.
Read our Latest News
Founder & Non-Executive Director
B. Com (Hons) CA
Ian qualified as a Chartered Accountant in Edinburgh moving into banking in the early 90s. At Bank of Scotland, Ian was Managing Director of Structured Finance, leading the Bank’s push into Europe from headquarters set up by Ian in Paris. He subsequently joined Candover Partners in London leading numerous private equity investments in the UK and Europe and retired as a Managing Director. Along with a few ex Candover colleagues, Ian set up 24Haymarket, the business angel group which now numbers 100 HNW individuals in London and 20 in Edinburgh. A few of these individuals are shareholders in LiverScan.
Professor Walter Nimmo
Walter Nimmo is a graduate in medicine from Edinburgh University. He is a retired professor of anaesthesia and was the chief executive of the Inveresk Research Group. He is a board member of several medical and diagnostic companies.
Chief Executive Officer & Executive Director
BA, ACMA & FCIOBS
Bruce is an experienced investor and board room leader. He spent 25 years in Corporate Banking post qualifying as an accountant leading a large team that looked after a £2bn investment portfolio. He is currently a non-executive director of Urban Logistics REIT plc a FTSE 250 company and Chairman of Hire and Supplies Limited a plant hire business based in Dumfries. Bruce is a Trustee of Edinburgh Athletic Club as well as an active coach. In his role as CEO, he is responsible for corporate and operational strategy.
Chief Operating Officer & Executive Director
BSc And MSc in Radiotherapy & Oncology
Claire is responsible for implementing the sales and marketing strategy and driving business growth. She has 8 years clinical experience in radiography and was previously the global sales manager of a healthcare ed tech company. Combining experience in both clinical and business/technology including; marketing, training and development, clinical sales support, product management, and leadership.
Chris qualified as a Bachelor of Veterinary Medicine and Surgery from the Royal Dick Veterinary College. After 3 years in farm practice, Chris returned to Edinburgh to co-found Braid Veterinary Hospital. This was Scotland’s first regulated animal hospital. In 1998 the hospital established another first in setting up a dedicated out-of-hours service providing emergency cover for other veterinary practices in the Edinburgh area.
Having been a long-term advocate of the benefits of preventative medicine, Chris is confident that LiverScan will make a measurable impact on early identification and management (and in many cases, resolution) of insidious liver disease.
LiverScan takes great pride in its approach to managing and conducting its operations. We are deeply committed to upholding the utmost standards in quality and customer engagement, IT security, health and safety, and environmental sustainability. You can download a copy of our certificates below.